 | | PRD_001005 | | Name: | N-(benzylsulfonyl)-3-cyclohexyl-D-alanyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | | Formula: | C29 H39 Cl N4 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000235 | | Name: | N-acetyl-L-leucyl-L-alanyl-N-[(1R,2R)-2-hydroxy-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}propyl]-L-alaninamide | | Formula: | C22 H39 N5 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000236 | | Name: | N-acetyl-L-alanyl-N-{(1S)-3,3-difluoro-1-(1-methylethyl)-2,4-dioxo-4-[(2-phenylethyl)amino]butyl}-L-prolinamide | | Formula: | C25 H37 F2 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001008 | | Name: | N~2~-(benzylsulfonyl)-D-arginyl-N-(4-carbamimidoylbenzyl)glycinamide | | Formula: | C23 H32 N8 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000237 | | Name: | N-({1-[(2S)-2-carboxy-4-phenylbutyl]cyclopentyl}carbonyl)-L-tryptophan | | Formula: | C28 H32 N2 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000238 | | Name: | Ac-Asp-Glu-Val-Asp-CMK | | Formula: | C21 H31 Cl N4 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001011 | | Name: | (3S)-4-hydroxy-3-{[(2S)-4-{[2-(2-methyl-1H-benzimidazol-1-yl)ethyl]amino}-2-(1-methylethyl)-4-oxobutanoyl]amino}butanoic acid | | Formula: | C21 H30 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000239 | | Name: | N-acetyl-L-alpha-aspartyl-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]-L-alaninamide | | Formula: | C19 H29 F N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000240 | | Name: | N-acetyl-L-isoleucyl-L-prolyl-L-Phenylalaninal | | Formula: | C22 H33 N3 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001013 | | Name: | Peptide Inhibitor (ACE)ADVAD-CHO | | Formula: | C21 H33 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000241 | | Name: | N-acetyl-L-leucyl-L-alpha-aspartyl-L-alpha-glutamyl-L-seryl-L-aspartic aldehyde | | Formula: | C24 H39 N5 O13 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000242 | | Name: | N-acetyl-L-leucyl-L-phenylalanyl-N-[(1S,2R)-1-(2-carboxyethyl)-3-fluoro-2-hydroxypropyl]-L-phenylalaninamide | | Formula: | C32 H43 F N4 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000243 | | Name: | N-acetyl-3-(naphthalen-1-yl)-L-alanyl-L-valyl-L-leucyl-L-alanyl-L-alpha-glutamyl-3-naphthalen-1-yl-
L-alaninamide | | Formula: | C47 H59 N7 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000244 | | Name: | (2R,4S)-N-tert-butyl-1-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}-2-hydroxy-4-phenylbutyl]-4-(pyridin-4-ylsulfonyl)piperidine-2-carboxamide | | Formula: | C35 H46 N4 O6 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001017 | | Name: | (S)-N-((1R,2S)-1-((2R,3R)-3-benzyloxiran-2-yl)-1-hydroxy-3-phenylpropan-2-yl)-3-methyl-2-(2-phenoxyacetamido)butanamide | | Formula: | C31 H36 N2 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000245 | | Name: | 1-acetyl-L-prolyl-L-prolyl-L-prolyl-L-valyl-N-(1-methylethyl)glycyl-L-prolyl-N~5~-[amino(iminio)methyl]-L-ornithyl-
N~5~-[amino(iminio)methyl]-L-ornithine | | Formula: | C44 H76 N14 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001019 | | Name: | (S)-N-((2S,3S,4R,5R)-4-amino-3,5-dihydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-phenoxyacetamido)butanamide | | Formula: | C31 H39 N3 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000246 | | Name: | N~2~-acetyl-N~5~-[amino(iminio)methyl]-L-ornithyl-L-alpha-glutamyl-N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-N~5~-
[amino(iminio)methyl]-L-ornithinamide | | Formula: | C26 H52 Cl N11 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000247 | | Name: | N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-L-leucyl-L-phenylalaninamide | | Formula: | C23 H36 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001020 | | Name: | GDC0152 | | Formula: | C25 H34 N6 O3 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000249 | | Name: | N~1~-(3-aminobenzyl)-N~2~-[(2R)-2-(hydroxycarbamoyl)-4-methylpentanoyl]-L-aspartamide | | Formula: | C18 H27 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001021 | | Name: | INHIBITOR ARC-670 | | Formula: | C53 H103 N31 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000250 | | Name: | N-acetyl-L-valyl-O-benzyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-{[(3R)-2-oxopyrrolidin-3-yl]methyl}propyl]-L-leucinamide | | Formula: | C32 H51 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001022 | | Name: | (2S,5S,8S,13S,16Z)-5-benzyl-2-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxylic acid | | Formula: | C36 H46 N8 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001023 | | Name: | (2S,5S,8S,13S,16Z)-5-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-2-(3-phenylprop-2-en-1-yl)-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxamide | | Formula: | C38 H49 N9 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
